N-(4-(chlorodifluoromethoxy)phenyl)-6-(4-(4-(6-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)thio)hexyl)piperazin-1-yl)piperidin-1-yl)-5-(1H-pyrazol-3-yl)nicotinamide

ID: ALA5279955

Chembl Id: CHEMBL5279955

Max Phase: Preclinical

Molecular Formula: C44H50ClF2N9O5S

Molecular Weight: 890.46

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1CCC(N2Cc3c(SCCCCCCN4CCN(C5CCN(c6ncc(C(=O)Nc7ccc(OC(F)(F)Cl)cc7)cc6-c6ccn[nH]6)CC5)CC4)cccc3C2=O)C(=O)N1

Standard InChI:  InChI=1S/C44H50ClF2N9O5S/c45-44(46,47)61-32-10-8-30(9-11-32)50-41(58)29-26-34(36-14-17-49-52-36)40(48-27-29)55-19-15-31(16-20-55)54-23-21-53(22-24-54)18-3-1-2-4-25-62-38-7-5-6-33-35(38)28-56(43(33)60)37-12-13-39(57)51-42(37)59/h5-11,14,17,26-27,31,37H,1-4,12-13,15-16,18-25,28H2,(H,49,52)(H,50,58)(H,51,57,59)

Standard InChI Key:  QRGISIMVAZWDHL-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5279955

    ---

Associated Targets(Human)

K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABL1 Tclin Cereblon/BCR/ABL (220 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABL1 Tclin Tyrosine-protein kinase ABL (18331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-937 (7138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABL1 Tclin Bcr/Abl fusion protein (1667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
STAT5A Tchem Signal transducer and activator of transcription 5A (227 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CRKL Tbio Crk-like protein (7 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 890.46Molecular Weight (Monoisotopic): 889.3312AlogP: 6.59#Rotatable Bonds: 16
Polar Surface Area: 156.10Molecular Species: BASEHBA: 11HBD: 3
#RO5 Violations: 3HBA (Lipinski): 14HBD (Lipinski): 3#RO5 Violations (Lipinski): 3
CX Acidic pKa: 10.71CX Basic pKa: 8.55CX LogP: 5.95CX LogD: 4.77
Aromatic Rings: 4Heavy Atoms: 62QED Weighted: 0.05Np Likeness Score: -1.22

References

1. Liu H, Mi Q, Ding X, Lin C, Liu L, Ren C, Shen S, Shao Y, Chen J, Zhou Y, Ji L, Zhang H, Bai F, Yang X, Yin Q, Jiang B..  (2022)  Discovery and characterization of novel potent BCR-ABL degraders by conjugating allosteric inhibitor.,  244  [PMID:36306539] [10.1016/j.ejmech.2022.114810]

Source